Aurinia Pharmaceuticals Inc. (AUPH) DCF Valuation

Aurinia Pharmaceuticals Inc. (AUPH) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Aurinia Pharmaceuticals Inc. (AUPH) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess Aurinia Pharmaceuticals Inc.'s intrinsic value? Our AUPH DCF Calculator integrates real-time data with extensive customization features, allowing you to adjust forecasts and enhance your investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .3 50.1 45.6 134.0 175.5 272.9 424.3 659.8 1,025.8 1,595.0
Revenue Growth, % 0 15660.38 -9 193.89 30.95 55.49 55.49 55.49 55.49 55.49
EBITDA -89.8 -102.9 -177.4 -103.6 -63.0 -225.6 -350.7 -545.3 -847.9 -1,318.3
EBITDA, % -28230.19 -205.35 -389.09 -77.33 -35.92 -82.65 -82.65 -82.65 -82.65 -82.65
Depreciation 1.2 1.4 2.8 2.7 11.6 64.1 99.7 155.0 241.0 374.7
Depreciation, % 368.24 2.74 6.05 2.02 6.64 23.49 23.49 23.49 23.49 23.49
EBIT -90.9 -104.3 -180.2 -106.4 -74.7 -230.3 -358.0 -556.7 -865.6 -1,345.9
EBIT, % -28598.43 -208.09 -395.15 -79.35 -42.56 -84.38 -84.38 -84.38 -84.38 -84.38
Total Cash 306.0 398.3 466.1 389.4 350.5 272.9 424.3 659.8 1,025.8 1,595.0
Total Cash, percent .1 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .4 .0 15.4 13.5 24.1
Account Receivables, % 115.72 0 33.8 10.06 13.72
Inventories .0 13.9 19.3 24.8 39.7 60.7 94.4 146.8 228.3 354.9
Inventories, % 0 27.79 42.38 18.47 22.62 22.25 22.25 22.25 22.25 22.25
Accounts Payable 4.2 2.6 3.9 3.1 4.3 64.7 100.6 156.4 243.2 378.1
Accounts Payable, % 1305.97 5.26 8.51 2.3 2.47 23.71 23.71 23.71 23.71 23.71
Capital Expenditure -.1 -7.3 -1.5 -.3 -.7 -28.0 -43.5 -67.7 -105.2 -163.6
Capital Expenditure, % -32.7 -14.65 -3.29 -0.21786 -0.40909 -10.25 -10.25 -10.25 -10.25 -10.25
Tax Rate, % -0.71125 -0.71125 -0.71125 -0.71125 -0.71125 -0.71125 -0.71125 -0.71125 -0.71125 -0.71125
EBITAT -91.0 -104.2 -181.0 -108.2 -75.2 -230.2 -358.0 -556.6 -865.5 -1,345.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -86.2 -125.2 -199.3 -110.1 -88.6 -216.7 -347.3 -540.1 -839.7 -1,305.7
WACC, % 10.85 10.85 10.85 10.85 10.85 10.85 10.85 10.85 10.85 10.85
PV UFCF
SUM PV UFCF -2,211.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1,332
Terminal Value -15,051
Present Terminal Value -8,994
Enterprise Value -11,205
Net Debt 49
Equity Value -11,253
Diluted Shares Outstanding, MM 143
Equity Value Per Share -78.57

What You Will Get

  • Comprehensive AUPH Financials: Access historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Explore various scenarios to assess Aurinia’s future performance.
  • User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Data: Aurinia Pharmaceuticals Inc.'s historical financial statements and pre-filled forecasts.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Observe Aurinia's intrinsic value recalculating instantly.
  • Intuitive Visuals: Dashboard charts present valuation results and essential metrics clearly.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance specialists.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Aurinia Pharmaceuticals Inc. (AUPH) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Aurinia Pharmaceuticals Inc.'s (AUPH) intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose Aurinia Pharmaceuticals Inc. (AUPH)?

  • Innovative Solutions: Pioneering therapies that address unmet medical needs in kidney diseases.
  • Strong Pipeline: Robust research and development efforts aimed at delivering impactful treatments.
  • Expert Team: Led by industry veterans with extensive experience in pharmaceuticals and biotechnology.
  • Commitment to Quality: Adherence to the highest standards in clinical trials and product development.
  • Proven Track Record: Demonstrated success in bringing effective therapies to market.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Aurinia Pharmaceuticals Inc. (AUPH) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Aurinia Pharmaceuticals Inc. (AUPH).
  • Consultants: Deliver professional valuation insights on Aurinia Pharmaceuticals Inc. (AUPH) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Aurinia Pharmaceuticals Inc. (AUPH) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Aurinia Pharmaceuticals Inc. (AUPH).

What the Template Contains

  • Historical Data: Includes Aurinia Pharmaceuticals Inc.'s (AUPH) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Aurinia Pharmaceuticals Inc.'s (AUPH) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Aurinia Pharmaceuticals Inc.'s (AUPH) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.